SCHEMBL6934540

SCHEMBL6934540

[CH2]CC(C)OCCCCCC

nearest known ligand 0.47

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 1/20 0.47
TSHR P16473 3/20 0.36
THRB P10828 2/20 0.36
LPAR1 Q92633 4/20 0.36
LPAR3 Q9UBY5 4/20 0.36
LPAR2 Q9HBW0 1/20 0.36
MEN1 O00255 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
MAPT P10636 1/20 0.35
USP2 O75604 1/20 0.35
SPHK1 Q9NYA1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6939087 1.00 DNM1 (0.47) DNM1TSHRTHRBLPAR1LPAR3
SCHEMBL6937785 1.00 DNM1 (0.47) DNM1TSHRTHRBLPAR1LPAR3
SCHEMBL6934689 1.00 DNM1 (0.47) DNM1TSHRTHRBLPAR1LPAR3
SCHEMBL6940334 1.00 DNM1 (0.47) DNM1TSHRTHRBLPAR1LPAR3
SCHEMBL6934387 1.00 DNM1 (0.47) DNM1TSHRTHRBLPAR1LPAR3
SCHEMBL6934843 1.00 DNM1 (0.47) DNM1TSHRTHRBLPAR1LPAR3
SCHEMBL4499214 0.98 DNM1 (0.43) DNM1TSHRTHRBLPAR1LPAR3
SCHEMBL20379 0.91
SCHEMBL9428105 0.83 DNM1 (0.44) DNM1TSHRTHRBLPAR1LPAR3
SCHEMBL9427755 0.83 DNM1 (0.44) DNM1TSHRTHRBLPAR1LPAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210353555-A1 NANOPARTICLES BASED ON OPTIONALLY ALKOXYLATED POLY(ALKYL CYANOACRYLATES) HAVING A DEFINED DEGREE OF POLYMERIZATION AbbVie Deutschland GmbH & Co. KG (DE) 2021-11-18 US disclosed
EP-3377110-B1 NANOPARTICLES BASED ON OPTIONALLY ALKOXYLATED POLY(ALKYL CYANOACRYLATES) HAVING A DEFINED DEGREE OF POLYMERIZATION ABBVIE DEUTSCHLAND (DE) 2021-01-06 EP disclosed
US-20180325833-A1 NANOPARTICLES BASED ON OPTIONALLY ALKOXYLATED POLY(ALKYL CYANOACRYLATES) HAVING A DEFINED DEGREE OF POLYMERIZATION AbbVie Deutschland GmbH & Co. KG (DE) 2018-11-15 US disclosed
EP-3377110-A1 NANOPARTICLES BASED ON OPTIONALLY ALKOXYLATED POLY(ALKYL CYANOACRYLATES) HAVING A DEFINED DEGREE OF POLYMERIZATION AbbVie Deutschland GmbH & Co. KG (DE) 2018-09-26 EP disclosed
EP-0962445-B1 Acetylene compound, liquid crystal composition and liquid crystal element MITSUI CHEMICALS INC (JP) 2003-02-26 EP disclosed
EP-0751133-B1 Pyrimidine compound, and liquid crystal composition and liquid crystal element using the same MITSUI CHEMICALS INC (JP) 2001-09-12 EP disclosed
US-6217793-B1 Acetylene compound, liquid crystal composition and liquid crystal element MITSUI CHEMICALS, INC. (JP) 2001-04-17 US disclosed
EP-0962445-A1 Acetylene compound, liquid crystal composition and liquid crystal element Mitsui Chemicals, Inc. (JP) 1999-12-08 EP disclosed
US-5770108-A HIGH SPEED RESPONSE, MOLECULAR ORIENTATION, HIGH CONTRAST, RECEPTIVITY MITSUI TOATSU CHEMICALS, INC. (JP) 1998-06-23 US disclosed
EP-0751133-A1 Pyrimidine compound, and liquid crystal composition and liquid crystal element using the same MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1997-01-02 EP disclosed
US-5290478-A Nitrile containing naphthylene compound SANYO CHEMICAL INDUSTRIES, LTD. (JP) 1994-03-01 US disclosed
EP-0385692-B1 OPTCALLY ACTIVE COMPOUNDS SANYO CHEMICAL INDUSTRIES LTD. (JP) 1993-10-06 EP disclosed
EP-0542381-A2 Optically active compounds SANYO CHEMICAL INDUSTRIES, LTD. (JP) 1993-05-19 EP disclosed
US-5160662-A Improved response times SANYO CHEMICAL INDUSTRIES, LTD. (JP) 1992-11-03 US disclosed
EP-0409634-A2 Liquid crystal compounds and optically active compounds SANYO CHEMICAL INDUSTRIES LTD. (JP) 1991-01-23 EP disclosed
EP-0385692-A2 Optcally active compounds SANYO CHEMICAL INDUSTRIES LTD. (JP) 1990-09-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180325833-A1 NANOPARTICLES BASED ON OPTIONALLY ALKOXYLATED POLY(ALKYL CYANOACRYLATES) HAVING A DEFINED DEGREE OF POLYMERIZATION CLTA, ACMSD, ALKBH3 DNM1 3826/4885TSHR 4883/4885THRB 4871/4885
US-20210353555-A1 NANOPARTICLES BASED ON OPTIONALLY ALKOXYLATED POLY(ALKYL CYANOACRYLATES) HAVING A DEFINED DEGREE OF POLYMERIZATION CLTA, ACMSD, ALKBH3 DNM1 3826/4885TSHR 4883/4885THRB 4871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.